New method allows tracking of HIV
A new method allows real-time-visualisation of how the HI virus spreads between living T helper cells and which molecules it requires for this purpose.
ADVERTISEMENT
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 2128 entries already.
Entries by Thomas Gabrielczyk
Successful EFIB in Brussels
How can biotechnology and bioeconomy contribute to establish a sustainable and circular economy? Nearly 500 attendees discussed latest trends at EFIB 2019 in Brussels.
Rottapharm Biotech: POC in osteoarthritis pain
Rottapharm Biotech (Monza, Italy) has published detailed results from a clinical Phase II trial of CR4056 in chronic pain from knee osteoarthritis.
Spanish sector attracting more and more investment
Spain’s biotech association Asebio announced new record numbers from its biotech investor day held as part of the European Biotech Week.
Creoptix AG closes CHF8m financing round
Swiss drug discovery analytics specialist Creoptix AG has raised CHF8m in a Series C financing for commercial expansion.
AMR: GARDP and Entasis Therapeutics start pivotal study
Entasis Therapeutics Inc (Waltham, USA) and non for profit organisation GARDP (Geneva, Switzerland) have initiated Phase III testing of the novel antibiotic zoliflodacin to treat infections with the WHO priority pathogen N. gonorrhoea.
BASF broadens biotech business by Isobionics acquisition
BASF SE has strengthened its capabilities in recombinant production of natural ingredients by acquiring Dutch Isobionics BV and collaborating with Conagen Inc.
2nd ECP Summer Summit at Henkel HQ, Düsseldorf
290 participants from 18 nations at the late summer edition of the European Chemistry Partnering in Düsseldorf
- High level or participation from Southern and Eastern Europe
- Attendance record and more than 500 arranged networking meetings
- 4th European Chemistry Partnering will take place on 27 February 2020 in Frankfurt
- Podcast of the panel discussion Digitization Networking in Chemistry available soon
Gut bacterial enzyme keeps inflammation away
An antimicrobial molecule produced by the human microbiota gut may help fight drug-resistant infections.
Tacalyx GmbH raises €7m in seed funding
German Tacalyx GmbH has baged €7m in seed financing to generate antibodies that home in on tumour-antigene specific carbohydrates (TACAs) of glycans.